Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

NIH grant funds study to understand how chemical exposure impacts Alzheimer’s risk

To better understand how day-to-day exposures to chemicals earlier in life can contribute to conditions like Alzheimer's disease later on, researchers at the Perelman School of Medicine of the University of Pennsylvania, Northwestern University, University of California San Francisco, and Emory University received an $11 million National Institutes of Health grant

30 Oct 2024

Exercise linked to lower mortality risk in dementia patients

Physical activity of any intensity after a diagnosis of dementia is associated with around a 30% lower risk of death, finds research published online in the British Journal of Sports Medicine.

30 Oct 2024

Positive aging expectations linked to better cognitive perception

Getting older brings certain expectations, from gray hair and wrinkles to more bouts of forgetfulness. While these beliefs may seem harmless, whether a person views these changes in a positive or negative light may influence how they perceive their cognitive abilities, according to a new study from researchers in the Penn State College of Nursing.

29 Oct 2024

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Heather Snyder discusses the Alzheimer's Association's research initiatives, breakthroughs in diagnostics, and the importance of collaboration in dementia care.

28 Oct 2024

Scientists uncover "superspreader" fibrils driving Alzheimer's Disease

The treatment of dementia disorders such as Alzheimer's is still one of the greatest challenges facing modern medicine. In the course of neurodegenerative diseases, certain proteins such as the amyloid β protein accumulate in the brain. They are suspected of being linked to the development of the disease, which is why they are considered a promising target for therapeutic approaches.

28 Oct 2024

Wayne State University researcher secures $2.3 million for Alzheimer's studies

A Wayne State University School of Medicine faculty member has been awarded a total of $2.3 million by the National Institute on Aging of the National institutes of Health for two new, concurrent projects that both address questions related to Alzheimer's disease, a progressive, age-related degenerative brain disease characterized by memory problems, impaired judgment, cognitive issues and changes in personality.

26 Oct 2024

Study links gut bacteria infection to Alzheimer's disease progression

A groundbreaking study by researchers at Florida State University's Gut Biome Lab has revealed a potential link between an infection caused by gut bacteria and the progression of Alzheimer's disease.

24 Oct 2024

Research uncovers new insights into neuronal aging and rejuvenation

When a neuron ages, it loses synaptic connections with other neurons, it is less able to transmit nerve impulses, and its metabolism is also altered. This process of neuronal aging — inevitable with the passing of time — is particularly accelerated and becomes a risk factor in neurodegenerative pathologies such as Alzheimer's disease.

24 Oct 2024

Brain aging may hold the key to predicting Alzheimer’s risk

Research reveals advanced brain aging in older adults correlates with cognitive decline and Alzheimer's risk, highlighting the need for early intervention.

24 Oct 2024

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Researchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

24 Oct 2024

Researchers create mini-brains to study autism and test new treatments

Using stem cells generated from patients with a rare and severe form of autism spectrum disorder and intellectual disability, Scripps Research scientists have grown personalized "mini-brains" (or organoids) to study the disorder in new detail.

23 Oct 2024

Medicare choices spark revolving door for older adults

Right now across the country, tens of millions of older adults and people with serious disabilities have a choice to make: whether to stick with their current Medicare option, or change during Open Enrollment.

22 Oct 2024

Bilingualism linked to greater brain resilience in older adults

Bilingualism has long been known to have cognitive benefits for older adults. Research shows it helping delay the onset of Alzheimer's disease by up to five years compared to monolingual adults.

22 Oct 2024

AI model analyzes retinal images to detect early Alzheimer’s disease and cognitive decline

Researchers developed an AI-based deep learning model that uses retinal images to detect early-stage Alzheimer's disease and mild cognitive impairment with high accuracy, offering a noninvasive, cost-effective screening tool.

22 Oct 2024

Major study links loneliness to increased risk of dementia

New research led by Florida State University College of Medicine faculty quantified the association between loneliness and dementia by analyzing data from more than 600,000 people around the world -; the largest study of its kind.

21 Oct 2024

New study reveals molecular mechanism in Alzheimer's disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer's patients.

18 Oct 2024

The molecular underpinnings by which traumatic brain injury increases Alzheimer's disease risk

Findings indicate BAG3 modulation after traumatic brain injury may mitigate tau buildup and cognitive deficits, presenting a target for Alzheimer's prevention.

18 Oct 2024

Brazil-Italy joint lab focuses on Alzheimer’s drug development

A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer's disease.

17 Oct 2024

Boston University and GSK collaborate to tackle pulmonary fibrosis

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research focused on developing cutting-edge models to study and treat lung diseases like pulmonary fibrosis.

17 Oct 2024

Genetic analysis shows smoking and high BMI increase dementia risk, but education and exercise protect

Mendelian randomization of 400,000 participants reveals smoking, high BMI, and high cholesterol as major genetic risk factors for dementia, while longer education and physical activity reduce risks.

17 Oct 2024

Alzheimer's Disease News and Research

Further Reading

NIH grant funds study to understand how chemical exposure impacts Alzheimer’s risk

Exercise linked to lower mortality risk in dementia patients

Positive aging expectations linked to better cognitive perception

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Scientists uncover "superspreader" fibrils driving Alzheimer's Disease

Wayne State University researcher secures $2.3 million for Alzheimer's studies

Study links gut bacteria infection to Alzheimer's disease progression

Research uncovers new insights into neuronal aging and rejuvenation

Brain aging may hold the key to predicting Alzheimer’s risk

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Researchers create mini-brains to study autism and test new treatments

Medicare choices spark revolving door for older adults

Bilingualism linked to greater brain resilience in older adults

AI model analyzes retinal images to detect early Alzheimer’s disease and cognitive decline

Major study links loneliness to increased risk of dementia

New study reveals molecular mechanism in Alzheimer's disease

The molecular underpinnings by which traumatic brain injury increases Alzheimer's disease risk

Brazil-Italy joint lab focuses on Alzheimer’s drug development

Boston University and GSK collaborate to tackle pulmonary fibrosis

Genetic analysis shows smoking and high BMI increase dementia risk, but education and exercise protect

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News